Neogen Corporation Sales Revenue, Goods, Net (Deprecated 2018-01-31)
Neogen Corporation (NEOG) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $78.14 million for the 3-month period ending 2018-02-28, per its 10-Q filed 2018-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-03-29
- Neogen Corporation sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-02-28 was $78.14M, a 5.65% increase year-over-year.
- Neogen Corporation sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-11-30 was $85.59M, a 11.21% increase year-over-year.
- Neogen Corporation sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-08-31 was $80.57M, a 11.52% increase year-over-year.
- Neogen Corporation sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-05-31 was $83.34M, a 10.48% increase year-over-year.
- Neogen Corporation sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $306.51M, a 12.04% increase from fiscal 2016.
- Neogen Corporation sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $273.57M, a 12.16% increase from fiscal 2015.
- Neogen Corporation sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $243.91M, a 12.84% increase from fiscal 2014.
- Neogen Corporation sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $216.15M, a 17.39% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-02-28 | $78.14M 10-Q · filed 2018-03-29 | $163.73M derived: sum of 2 quarters · filed 2018-03-29 | $244.30M 10-Q · filed 2018-03-29 | $327.64M derived: sum of 4 quarters · filed 2018-03-29 | ||||
| 2017-11-30 | $85.59M 10-Q · filed 2018-01-05 | $166.16M 10-Q · filed 2018-01-05 | $249.50M derived: sum of 3 quarters · filed 2018-01-05 | $323.46M derived: sum of 4 quarters · filed 2018-03-29 | ||||
| 2017-08-31 | $80.57M 10-Q · filed 2017-09-29 | $163.91M derived: sum of 2 quarters · filed 2017-09-29 | $237.87M derived: sum of 3 quarters · filed 2018-03-29 | $314.83M derived: sum of 4 quarters · filed 2018-03-29 | ||||
| 2017-05-31 | $83.34M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $157.31M derived: sum of 2 quarters · filed 2018-03-29 | $234.27M derived: sum of 3 quarters · filed 2018-03-29 | $306.51M 10-K · filed 2017-07-28 | ||||
| 2017-02-28 | $73.96M 10-Q · filed 2018-03-29 | $150.93M derived: sum of 2 quarters · filed 2018-03-29 | $223.17M 10-Q · filed 2018-03-29 | $298.61M derived: sum of 4 quarters · filed 2018-03-29 | ||||
| 2016-11-30 | $76.96M 10-Q · filed 2018-01-05 | $149.21M 10-Q · filed 2018-01-05 | $224.65M derived: sum of 3 quarters · filed 2018-01-05 | $289.02M derived: sum of 4 quarters · filed 2018-01-05 | ||||
| 2016-08-31 | $72.25M 10-Q · filed 2017-09-29 | $147.68M derived: sum of 2 quarters · filed 2017-09-29 | $212.06M derived: sum of 3 quarters · filed 2017-09-29 | $280.78M derived: sum of 4 quarters · filed 2017-09-29 | ||||
| 2016-05-31 | $75.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $139.82M derived: sum of 2 quarters · filed 2017-07-28 | $208.53M derived: sum of 3 quarters · filed 2017-07-28 | $273.57M 10-K · filed 2017-07-28 | ||||
| 2016-02-29 | $64.38M 10-Q · filed 2017-03-31 | $133.09M derived: sum of 2 quarters · filed 2017-03-31 | $198.13M 10-Q · filed 2017-03-31 | $265.93M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-11-30 | $68.72M 10-Q · filed 2016-12-29 | $133.75M 10-Q · filed 2016-12-29 | $201.55M derived: sum of 3 quarters · filed 2017-07-28 | $259.61M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-08-31 | $65.04M 10-Q · filed 2016-09-30 | $132.83M derived: sum of 2 quarters · filed 2017-07-28 | $190.90M derived: sum of 3 quarters · filed 2017-07-28 | $250.72M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-05-31 | $67.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $125.86M derived: sum of 2 quarters · filed 2017-07-28 | $185.69M derived: sum of 3 quarters · filed 2017-07-28 | $243.91M 10-K · filed 2017-07-28 | $247.94M 10-K · filed 2015-07-30 | |||
| 2015-02-28 | $58.07M 10-Q · filed 2016-03-31 | $59.17M 10-Q · filed 2015-04-01 | $117.89M derived: sum of 2 quarters · filed 2016-03-31 | $176.11M 10-Q · filed 2016-03-31 | $179.21M 10-Q · filed 2015-04-01 | $233.06M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-11-30 | $59.82M 10-Q · filed 2016-01-08 | $60.78M 10-Q · filed 2014-12-30 | $118.05M 10-Q · filed 2016-01-08 | $120.03M 10-Q · filed 2014-12-30 | $175.00M derived: sum of 3 quarters · filed 2016-07-29 | $229.62M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-08-31 | $58.22M 10-Q · filed 2015-09-30 | $59.26M 10-Q · filed 2014-09-30 | $115.17M derived: sum of 2 quarters · filed 2016-07-29 | $169.80M derived: sum of 3 quarters · filed 2016-07-29 | $223.03M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2014-05-31 | $56.95M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $111.57M derived: sum of 2 quarters · filed 2016-07-29 | $164.80M derived: sum of 3 quarters · filed 2016-07-29 | $216.15M 10-K · filed 2016-07-29 | $219.73M 10-K · filed 2014-07-30 | |||
| 2014-02-28 | $54.62M 10-Q · filed 2015-04-01 | $107.85M derived: sum of 2 quarters · filed 2015-04-01 | $159.20M 10-Q · filed 2015-04-01 | $207.90M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-11-30 | $53.23M 10-Q · filed 2014-12-30 | $104.58M 10-Q · filed 2014-12-30 | $153.28M derived: sum of 3 quarters · filed 2015-07-30 | $197.40M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-08-31 | $51.35M 10-Q · filed 2014-09-30 | $100.05M derived: sum of 2 quarters · filed 2015-07-30 | $144.18M derived: sum of 3 quarters · filed 2015-07-30 | $190.67M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-05-31 | $48.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $92.83M derived: sum of 2 quarters · filed 2015-07-30 | $139.32M derived: sum of 3 quarters · filed 2015-07-30 | $184.13M 10-K · filed 2015-07-30 | ||||
| 2013-02-28 | $44.12M 10-Q · filed 2014-04-04 | $90.62M derived: sum of 2 quarters · filed 2014-04-04 | $135.43M 10-Q · filed 2014-04-04 | |||||
| 2012-11-30 | $46.49M 10-Q · filed 2014-01-09 | $91.31M 10-Q · filed 2014-01-09 | ||||||
| 2012-08-31 | $44.81M 10-Q · filed 2013-09-30 | |||||||
| 2012-05-31 | $164.91M 10-K · filed 2014-07-30 | |||||||
| 2011-05-31 | $154.66M 10-K · filed 2013-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |